Medical Procedure News

RSS

Eschar-derived cells may be used for tissue engineering

A research team in the Netherlands has found that cells from burn eschar, the non-viable tissue remaining after burn injury and normally removed to prevent infection, can be a source of mesenchymal cells that may be used for tissue engineering.

12 Jul 2012

Effective therapies to reduce perioperative morbidity and mortality remain elusive

Among intermediate- to high-risk patients undergoing coronary artery bypass graft surgery, administration of the agent acadesine to regulate adenosine (a naturally occurring chemical that dilates blood flow and can improve coronary blood flow and perfusion) did not reduce all-cause death, nonfatal stroke, or need for mechanical support for ventricular dysfunction, for approximately a month after surgery, according to a study in the July 11 issue of JAMA.

12 Jul 2012

BWH performs New England's first implant of SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.

11 Jul 2012

Chemotherapy improves survival for patients with periampullary cancer following resection

Patients who had surgery for periampullary cancer (a variety of types of cancer that are located in and near the head of the pancreas, including an area called the ampulla where the bile duct joins up with the pancreatic duct to empty their secretions into the upper small intestine) and received chemotherapy had a statistically significant survival benefit, compared to patients who did not receive chemotherapy, after adjusting for prognostic variables, according to a study in the July 11 issue of JAMA.

11 Jul 2012

Euthanasia and assisted suicide rates in the Netherlands comparable to rates before legalisation

2010 rates of euthanasia and assisted suicide in the Netherlands were comparable to levels before the practices were legalised in 2002, according to new research published Online First in The Lancet and conducted by a Dutch research team from Erasmus MC University Medical Centre, Rotterdam; VU University Medical Centre, Amsterdam; Statistics Netherlands, The Hague; and Utrecht’s University Medical Centre.

11 Jul 2012

Study investigates effect of SwabCap in catheter maintenance bundle

A disinfection cap used in IV therapy was the subject of an award-winning, multi-site study at a four-hospital, Chicago-area hospital system.

11 Jul 2012

K2M expands biologics portfolio

K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced a major expansion of the company’s U.S. biologics offering with the launch of its VESUVIUS™ Osteobiologic Systems and new additions to its VIKOS® Allograft Systems. K2M is working with LifeNet Health®, a leading allograft bio-implant and regenerative medicine company, to bring to market quality implants to enhance bone regeneration and osteoconductivity.

10 Jul 2012

New blood sugar monitor works better than conventional methods

Newer technologies designed to help people with type 1 diabetes monitor their blood sugar levels daily work better than traditional methods and require fewer painful needle sticks, new Johns Hopkins research suggests.

10 Jul 2012

$Vertebroplasty can benefit patients with osteoporotic vertebral compression fractures$

Vertebroplasty can benefit patients with osteoporotic vertebral compression fractures

An analysis of published data in the medical literature has found that vertebroplasty can provide more pain relief and better function for patients with osteoporotic vertebral compression fractures than nonoperative treatments.

10 Jul 2012

PENTAX Medical introduces EG-3270UK endoscope

PENTAX Medical sets a new standard in endoscopic ultrasound with the official launch of the EG-3270UK endoscope during the 30th GEEW congress in Brussels, Belgium.

From PENTAX Medical Company 10 Jul 2012

Roux-en-Y gastric bypass surgery induces changes in the gut microbiota

Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, finds that gastric bypass surgery induces changes in the gut microbiota and peptide release that are similar to those seen after treatment with prebiotics.

10 Jul 2012

UTSMC could play key role in operating a proton therapy center for North Texas

UT Southwestern Medical Center, seeking to broaden an already robust array of radiation oncology treatments it offers to patients, potentially could play a key role in operating a state-of-the-art proton therapy center for North Texas being planned and funded by San Diego-based Advanced Particle Therapy (APT).

10 Jul 2012

Special surface coating for stents to keep them in place

If a person's windpipe is constricted, an operation in which the surgeon inserts a stent to enlarge the trachea is often the only way to relieve their respiratory distress. But this grid-like implant can slip out of position, closing off the windpipe altogether. Researchers are working on a special surface coating for the stents to keep them in place.

9 Jul 2012

BioView, ScreenCell enter collaboration agreement for imaging of CTC

BioView Ltd. and ScreenCell, a privately-held company, today jointly announced the signing of a commercial collaboration agreement for Bioview's Automated Cell Imaging Systems for imaging of CTC's isolated with ScreenCell's Cyto Kit.

9 Jul 2012

Stroke Telemedicine: An interview with Séamus Watson

Stroke is the third largest cause of death in England. (1) It is a condition that requires rapid assessment and treatment to reduce deaths, disability and the risk of having another stroke. (2)

9 Jul 2012

Cook Medical receives FDA clearance for Evolution Colonic Controlled-Release Stent

The U.S. Food and Drug Administration (FDA) has granted Cook Medical 510(k) clearance for the Evolution Colonic Controlled-Release Stent, Cook announced today.

9 Jul 2012

Novel system to treat hair loss receives CE Mark approval

Restoration Robotics, Inc., a privately-held medical device company, today announced its revolutionary ARTAS System received CE Mark Certificate to market in the European Union. The ARTAS System is the first physician controlled, computer assisted technology that allows harvesting individual follicular units directly from the scalp.

9 Jul 2012

Spacelabs receives FDA 510(k) clearance for Blease900 Ventilator

Spacelabs Healthcare today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for the Blease900 Ventilator - an integral component of its BleaseFocus anesthesia system - paving the way for launch of the new BleaseFocus anesthesia system to healthcare facilities in the United States.

9 Jul 2012

ReDent Nova reaches new global agreement with Henry Schein

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, and ReDent Nova, a Tel Aviv-based dental company, have reached a new global agreement.

9 Jul 2012

FDA approves Capricor’s IND application for myocardial infarction study

Capricor, Inc., a privately held biotechnology company focused on regenerative medicine, today announced that the U.S. Food and Drug Administration has approved initiation of its Investigational New Drug (IND) application for the ALLSTAR study, which will use allogeneic cardiac-derived stem cells (CDCs) to treat patients following large myocardial infarctions (MI).

9 Jul 2012